CD163 and cancer: The cross-talk between mesenchymal cancer cells and tumor microenvironment is recognized as a key factor in tumor progression in several tumors.10–12,14,30 However, we demonstrated that CD163-positive M2 TAMs did not retain their prognostic significance in multivariate analysis.